4.5 Article

How do mechanical circulatory support patients die? Autopsy findings for left-ventricular assist device/total artificial heart nonsurvivors

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 42, 期 12, 页码 1753-1763

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2023.07.001

关键词

LVAD; mechanical circulatory support; heart transplantation; bridge to transplant

向作者/读者索取更多资源

This study aimed to determine the frequency and outcomes of autopsy investigations in patients who died prior to heart transplantation after receiving permanent mechanical circulatory support.
BACKGROUND: Although life saving for end-stage heart failure patients, permanent mechanical circulatory support (MCS) is often the proximate cause of death in those that do not survive to transplant. Autopsy remains the gold standard for diagnosing causes of death and a vital tool for better under-standing underlying pathology of nonsurvivors. The aim of this study was to determine the frequency and outcomes of autopsy investigations and compare these with premortem clinical assessment.METHODS: The autopsy findings and medical records of all patients who underwent left ventricular assist device (LVAD) or total artificial heart (TAH) insertion between June 1994 and April 2022 as a bridge to transplant, but subsequently died pre-heart transplantation were reviewed.RESULTS: A total of 203 patients had a LVAD or TAH implanted during the study period. Seventy-eight patients (M = 59, F = 19) died prior to transplantation (age 55 [14] years, INTERMACS = 2). Autopsies were conducted in 26 of 78 patients (33%). Three were limited studies. The leading contributor to cause of death was respiratory (14/26), either nosocomial infection or associated with multiorgan failure. Intracranial hemorrhage was the second most common cause of death (8/26). There was a major discrepancy rate of 17% and a minor discrepancy rate of 43%. Autopsy study added a total of 14 additional contributors of death beyond clinical assessment alone (Graphical Abstract).CONCLUSIONS: Over an observational period of 26 years, the frequency of autopsy was low. To improve LVAD/TAH patient survival to transplant, better understanding as to cause of death is required. Patients with MCS have complex physiology and are at high risk of infection and bleeding complications. J Heart Lung Transplant 2023;42:1753-1763Crown Copyright (c) 2023 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据